Phathom Pharmaceuticals, Inc. financial statements
Phathom Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 175.11M | 10-K |
| Net income | −USD 221.25M | 10-K |
| Cash and equivalents | USD 129.97M | 10-Q |
| Total debt | USD 209.09M | 10-Q |
Phathom Pharmaceuticals, Inc. financials on 6ix · Phathom Pharmaceuticals, Inc. on 6ix